Stay updated on Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial page.

Latest updates to the Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision banner updated to v3.4.2; the previous notices about funding lapses and operating status were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check20 days agoChange DetectedA site-wide notice about government funding delays and current operating status is added, and the page shows a revision update to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check28 days agoChange DetectedThe page now includes a Show glossary toggle and new metadata labels: Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. The older labels Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 were removed.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now shows Revision: v3.3.4 instead of v3.3.3, indicating a minor update. No changes to the study details or content are evident.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded New York as a location under the Locations section and updated the page to revision 3.3.3; the old 'New York Locations' listing and the 'HHS Vulnerability Disclosure' footer link were removed.SummaryDifference0.2%

- Check91 days agoChange DetectedUpdated revision from v3.2.0 to v3.3.2; no study details or outcomes appear to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial page.